Pharma Strategy Lookouts: Dizal Pharmaceutical, JV of AstraZeneca in China
Posted on28 Nov 2017
TagsAstraZenca, Dapagliflozin, Dizal Pharmaceutical, Farxiga, osimertinib, SGLT-2 inhibitor, Tagrisso, Type 2 Diabetes
Comments0
AstraZeneca today announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China... Read More
New Brand Launch: Biocon introducing KRABEVA, a biosimilar Bevacizumab
Posted on24 Nov 2017
Comments0
Biocon Ltd, Asia’s premier biopharmaceuticals company, has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and... Read More
Brexit Effect: The European Medicines Agency’s (EMA) headquarters to move from London to Amsterdam
The European Council on Monday voted to move the European Medicines Agency’s (EMA) headquarters and nearly 900 staffers from London to Amsterdam,... Read More
Strides Shasun to disinvest India Generic Business; Eris Lifescience to acquire at 500 Crores
Eris Lifesciences has entered into a definitive agreement to acquire India branded generics business of Strides Shasun for an aggregate cash consideration... Read More
Torrent Pharma’s Expansion: Planning to acquire Unichem’s India business
India’s leadning pharma major Torrent Pharmaceuticals Ltd is looking for the possible acquisition of the domestic business of Unichem Laboratories. Similar acquisition... Read More
Under USFDA, do OTC medications has same approval process as that of prescription drugs?
No. Because there are over 300,000 marketed OTC drug products, instead of individual drug products, FDA reviews the active ingredients and the... Read More
US FDA New Indication Approval: Janssen Pharma’s 10mg dosing for Xarelto to reduce the risk of VTE
Janssen Pharmaceuticals has announced the US Food and Drug Administration (FDA) approved the 10 mg once-daily dose of Xarelto (rivaroxaban) for reducing... Read More
Alembic Pharma acquires US-based drug developer Orbit Labs
Alembic Pharma today announced that it has completed the acquisition of US-based generic drug developer Orbit Laboratories LLC, along with its real... Read More